Gland Pharma Limited — Others, 28-02-2025: Shareholders meeting

Gland Pharma has announced a board meeting to seek shareholder approval via postal ballot for the 'Gland Pharma Employee Stock Option Scheme 2025.' This scheme aims to issue a maximum of 29,82,124 employee stock options, translating to 1.81% of the company’s equity share capital, thereby promoting employee engagement and retention. The options will be granted based on a performance evaluation, incentivizing employees to align their goals with the company’s growth. This strategic move is anticipated to enhance employee motivation and satisfaction. Overall, this could foster a positive outlook among investors as it indicates a focus on long-term value creation.